Latest News and Press Releases
Want to stay updated on the latest news?
-
COVINA, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- COVINA, Calif. — Robert H. Curry, the Chief Executive Officer of Emanate Health—who guided the health care system to financial health, leveraged...
-
Raleigh, North Carolina, Nov. 30, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, today announced preparedness to detect the...
-
Fort Myers, Florida, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the following promotions and additions to its senior...
-
JERUSALEM, Nov. 23, 2021 (GLOBE NEWSWIRE) -- KAHR, a cancer immunotherapy company developing novel multifunctional immune-recruitment proteins, today announced it will host a virtual key opinion...
-
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP) today announced that after 10 years of service to CAP members, Deidri (Dee) Hoppe, President and...
-
Two key opinion leaders will discuss gout treatment landscape and perspectives on Phase 2 TARGETS study of DYV702 for the treatment of pain associated with acute gout flares Webinar to be...
-
Study results demonstrate first small molecule approach to significantly reduce phosphorylated and aggregated -synuclein and increase GCase protein levels with transport to the lysosomes in iPSC...
-
-CGuard™ sales generated 24% YoY revenue growth- -CGuard™ EPS received a positive opinion from the French National Authority for Health (HAS) regarding reimbursement in France- - $37.1 million in...
-
DENVER, Nov. 09, 2021 (GLOBE NEWSWIRE) -- EDCare is pleased to announce the appointment of Riley Nickols, Ph.D., CEDS, to its Scientific Advisory Board. A highly experienced counseling and sports...
-
TEL AVIV, Israel, Nov. 03, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...